Please provide your email address to receive an email when new articles are posted on . Reintervention rates were higher for hysteroscopic myomectomy, uterine artery embolization and endometrial ...
REDWOOD CITY, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Gynesonics ®, Inc. a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback